Cardiotoxicity of adjuvant chemotherapy with trastuzumab: a Japanese claim-based data analysis

OBJECTIVE: Adjuvant chemotherapy with trastuzumab improves the postoperative life expectancy of women with early-stage breast cancer. Although trastuzumab is reportedly cardiotoxic, quantification based on real-world evidence is lacking. Therefore, in this study, we aimed to analyse trastuzumab card...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohtsu, Hiroshi, Shimomura, Akihiko, Miyazaki, Sakiko, Yonemoto, Naohiro, Ueda, Shinichiro, Shimizu, Chikako, Sase, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Heart Failure and Cardiomyopathies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403121/
https://www.ncbi.nlm.nih.gov/pubmed/35995458
http://dx.doi.org/10.1136/openhrt-2022-002053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403121/
https://www.ncbi.nlm.nih.gov/pubmed/35995458
http://dx.doi.org/10.1136/openhrt-2022-002053

Ejemplares similares